Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Cutaneous sclerosis"
Show Display Options
Rank Status Study
1 Active, not recruiting Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Conditions: Graft vs Host Disease;   Cutaneous Sclerosis;   Bronchiolitis Obliterans
Intervention:
2 Active, not recruiting Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease;   Systemic Scleroderma
Interventions: Drug: imatinib mesylate;   Biological: rituximab;   Other: laboratory biomarker analysis;   Other: questionnaire administration

Indicates status has not been verified in more than two years